Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Sigal Elliot
Relationship:   Director
City:   Princeton
State:   NJ
   
Insider Summary:
  
   
Companies Owned :   3    
Direct Shares   148,221    

Indirect Shares

   78,638      
Direct Value   $6,188,227    

Indirect Value

   $5,549,704      
Total Shares   226,859      
Total Value   $11,737,931      


Bristol-Myers Squibb Co $6,188,227 Bristol-Myers Squibb Co $6,188,227
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    0    

     Stock price went up :
    0   
    0    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Bristol-Myers Squibb Co BMY EVP, CSO & President R... 2013-06-03 148,221 2013-06-03 47,079    Premium*  
            Mead Johnson Nutrition Co MJN Director 2017-06-15 0 2017-06-15 0    Premium*  
            Spark Therapeutics, Inc. ONCE Director 2019-12-17 0 2015-02-04 31,559    Premium*  
* Premium Members only  

Records found :    133         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 4 of 6
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
BMY Bristol-Myers Squibb Co EVP, CSO & President R&D   •       •      –    2011-03-02 4 A $0.00 $0 D/D 441 212,903 0 -
BMY Bristol-Myers Squibb Co EVP, CSO & President R&D   •       •      –    2011-03-02 4 OE $0.00 $0 D/D 12,062 212,462 0 -
BMY Bristol-Myers Squibb Co EVP, CSO & President R&D   •       •      –    2011-03-02 4 D $0.00 $0 D/D (5,796) 207,107 0 -
BMY Bristol-Myers Squibb Co EVP, CSO & President R&D   •       •      –    2011-03-04 4 OE $0.00 $0 D/D 7,452 214,559 0 -
BMY Bristol-Myers Squibb Co EVP, CSO & President R&D   •       •      –    2011-03-04 4 D $26.43 $91,316 D/D (3,455) 211,104 0 -
BMY Bristol-Myers Squibb Co EVP, CSO & President R&D   •       •      –    2011-03-06 4 D $26.43 $84,232 D/D (3,187) 214,792 0 -
BMY Bristol-Myers Squibb Co EVP, CSO & President R&D   •       •      –    2011-03-06 4 OE $0.00 $0 D/D 6,875 217,979 0 -
BMY Bristol-Myers Squibb Co EVP, CSO & President R&D   •       •      –    2011-03-07 4 D $26.31 $93,506 D/D (3,554) 211,238 0 -
BMY Bristol-Myers Squibb Co EVP, CSO & President R&D   •       •      –    2011-05-16 4 OE $28.90 $7,502,803 D/D 259,600 470,838 0 -
BMY Bristol-Myers Squibb Co EVP, CSO & President R&D   •       •      –    2011-05-16 4 S $28.90 $2,046,265 D/D (70,805) 372,572 0 -
BMY Bristol-Myers Squibb Co EVP, CSO & President R&D   •       •      –    2011-05-16 4 D $28.90 $6,609,201 D/D (228,681) 171,352 0 -
BMY Bristol-Myers Squibb Co EVP, CSO & President R&D   •       •      –    2011-05-18 4 D $28.70 $4,313,747 D/D (150,299) 205,902 0 -
BMY Bristol-Myers Squibb Co EVP, CSO & President R&D   •       •      –    2011-05-18 4 OE $28.70 $5,326,321 D/D 185,579 356,931 0 -
BMY Bristol-Myers Squibb Co EVP, CSO & President R&D   •       •      –    2011-05-18 4 S $28.70 $20,952 D/D (730) 356,201 0 -
BMY Bristol-Myers Squibb Co EVP, CSO & President R&D   •       •      –    2012-03-01 4 OE $0.00 $0 D/D 11,714 217,616 0 -
BMY Bristol-Myers Squibb Co EVP, CSO & President R&D   •       •      –    2012-03-01 4 A $0.00 $0 D/D 3,173 220,789 0 -
BMY Bristol-Myers Squibb Co EVP, CSO & President R&D   •       •      –    2012-03-01 4 D $32.64 $176,648 D/D (5,412) 215,377 0 -
BMY Bristol-Myers Squibb Co EVP, CSO & President R&D   •       •      –    2012-03-02 4 A $0.00 $0 D/D 3,866 231,305 0 -
BMY Bristol-Myers Squibb Co EVP, CSO & President R&D   •       •      –    2012-03-02 4 D $32.59 $240,612 D/D (7,383) 223,922 0 -
BMY Bristol-Myers Squibb Co EVP, CSO & President R&D   •       •      –    2012-03-02 4 OE $0.00 $0 D/D 12,062 227,439 0 -
BMY Bristol-Myers Squibb Co EVP, CSO & President R&D   •       •      –    2012-03-03 4 D $32.59 $700,392 D/D (21,491) 248,796 0 -
BMY Bristol-Myers Squibb Co EVP, CSO & President R&D   •       •      –    2012-03-03 4 OE $0.00 $0 D/D 46,365 270,287 0 -
BMY Bristol-Myers Squibb Co EVP, CSO & President R&D   •       •      –    2012-03-04 4 OE $0.00 $0 D/D 7,453 256,249 0 -
BMY Bristol-Myers Squibb Co EVP, CSO & President R&D   •       •      –    2012-03-04 4 D $32.59 $112,598 D/D (3,455) 252,794 0 -
BMY Bristol-Myers Squibb Co EVP, CSO & President R&D   •       •      –    2012-03-06 4 OE $0.00 $0 D/D 85,830 338,624 0 -
  133  Records found
  1   2   3   4  5   6      
  Page 4 of 6  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us